baber/WOPTO huggingface dataset:
Patent MX-2009012811-A (MX)
Title: Compact strip or thin slab processing of boron/titanium steels.
Inventor: VALDEZ MARTIN EMILIANO
IPC: C22C38/00
Filed: 2009-11-25
Abstract: A method for casting medium carbon, B/Ti steel product using compact strip processing or thin slab casting. The method can include providing a steel composition including boron and titanium and casting the steel composition into a slab having a thickness between about 25 and 150 mm. The slab can have a cast composition including about 0.23 to 0.30 wt. % carbon, about 0.0010 to 0.0050 wt. % boron, about 0.010 to 0.050 wt. % titanium, about 1.15 to 1.50 wt. % manganese, less than 0.35 wt. % silicon and a Ti/N ratio greater than 2.9. The amount of each element is provided based upon the total weight of the steel composition. The steel slab can be free from cracks and significant defects. Furthermore, the steel slab can be used for electric resistance welded (ERW) products.
Patent MX-2010001115-A (MX)
Title: Device, system, and method of adaptive teaching and learning.
Inventor: MEITAR SHMUEL
IPC: G09B19/00
Filed: 2007-08-29
Abstract: Device, system, and method of adaptive teaching and learning. For example, a teaching/learning system includes a real-time class management module to selectively allocate first and second digital learning objects for performance, substantially in parallel, on first and second student stations, respectively.
Patent MX-2010001461-A (MX)
Title: Ruggedized neutron shields.
Inventor: GIBSON JOSHUA WAYNE
IPC: G01V5/10
Filed: 2008-07-30
Abstract: A shield for a well logging instrument includes an outer layer including a reinforcing fiber disposed in a matrix and an inner layer including a thermal neutron absorbing material disposed in a matrix. The thermal neutron absorbing material is selected to emit capture gamma rays having energy outside a selected energy range.
Patent MX-2010002748-A (MX)
Title: Persistent resource allocation.
Inventor: BOURLAS YAIR
IPC: H04L12/28
Filed: 2008-09-04
Abstract: Methods and apparatus for communicating and utilizing persistent allocation of uplink resources are described herein. A base station can allocate persistent uplink resources to a client station, such that the resource allocation remains active for future uplink frames without the client station repeating a request for uplink resources or the base station expressly communicating the uplink resource allocation. A client station can request a persistent uplink resource allocation when wireless channel conditions are fairly consistent and not varying and the required uplink resources are predictably periodic and fixed in size. The base station can verify that the uplink resource request meets the criteria for persistent allocation and can allocate persistent uplink resources in a dedicated information element of an uplink resource map that is transmitted to the user. The resources allocated remain allocated to the client station in each frame satisfying a predetermined periodicity until deallocated.
Patent MX-2010004511-A (MX)
Title: Chelating composition for treating congenital water.
Inventor: GONZALEZ PEDRO SANCHEZ
IPC: A61K8/73
Filed: 2010-04-23
Abstract: Chelating composition for obtaining congenital water with a reduced hardness so as to be used in injection wells and contribute to solve the scale problem in piping and equipments of a congenital water treating plant.
Patent MX-2010005475-A (MX)
Title: Lidocaine as a transformer and producer of transformed complexes of drugs delivered in nano-dosages using injection implants as prolonged release devices.
Inventor: FLORES ALEJANDRA ZEPEDA
IPC: A61K9/08
Filed: 2010-05-19
Abstract: Lidocaine as a transformer and producer of transformed complexes of drugs delivered in nano-dosages using injection implants. The invention relates to a specific method based on suitable quantities of lidocaine for the transformation of drugs approved by the FDA and COFEPRIS, either in liquid or lyophilised form, producing nano-dosages that do not reduce the effectiveness or the therapeutic effects of the drug, converting same into lidocaine-drug complexes. The transformation method, which results in an end product comprising the fusion of molecules of lidocaine with one or more substances comprising drugs, the prior art and the different methods, techniques and instruments result in the formation of intelligent transformed complexes which can be implanted by means of injection close to the specific receptors, characterised by a release that lasts between 8 and 10 days.
Patent MX-2010011364-A (MX)
Title: Sealing jaw for producing sealed packages of a food product.
Inventor: MANCIN SERGIO
IPC: B65B51/30
Filed: 2009-04-27
Abstract: A sealing jaw (1) for producing sealed packages of a food product from a tube (3) of packaging material fed along a path (A), the jaw having a first work surface (28) which interacts with a second work surface (29) on a counter-jaw (2) to grip the packaging material and form a sealing strip (6) crosswise to the path (A); one (1) of the jaw and counter-jaw (1, 2) defining an anvil (9), and the other (2) of the jaw and counter-jaw (1, 2) defining heating means (8) which interact with the anvil (9) to form the strip (6). The first surface (28) has at least two projections (35, 36; 36, 36; 36, 37) elongated along respective first axes (X), and which, when forming the strip (6), compress respective areas of the packaging material against the second surface (29); and at least one cavity (40) which extends along one of the first axes (X), is interposed between the projections (35, 36; 36, 36; 36, 37) along a second axis (Y) crosswise to the first axis (X), and is located laterally with respect to a central plane (P) of the first work surface (28).
Patent MX-2010011878-A (MX)
Title: Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate.
Inventor: COHEN DANIEL
IPC: A61P25/28
Filed: 2009-04-29
Abstract: The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that modulate synapse function for treating said disease.
Patent MX-2010012249-A (MX)
Title: Inhibitors of jnk.
Inventor: DUNN JAMES PATRICK
IPC: A61P29/00
Filed: 2009-05-06
Abstract: The invention relates to prodrugs of JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses prodrugs of JNK inhibitors, as described below in formula (I), wherein m, n, p, q, Q, r, R1, R2, R3, X, X1, X2, X3, X4, X5, Y1, Y2, Z1, and Z2 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.
Patent MX-2011001351-A (MX)
Title: Monoclonal antibodies against tissue factor pathway inhibitor (tfpi).
Inventor: JIANG HAIYAN
IPC: C12P21/08
Filed: 2009-08-04
Abstract: Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided.
Patent MX-2011001980-A (MX)
Title: Gene expression profiles associated with lean phenotype and uses thereof.
Inventor: PAN YUANLONG
IPC: C07H21/02
Filed: 2009-08-10
Abstract: Gene expression profiles associated with improved or maintained lean body mass or reduced body fat are disclosed. The gene expression profiles were determined in adipose, liver, and muscle tissue of animals subjected to lean-promoting regimens such as consumption of a high protein diet, ingestion of conjugated linolenic acid, and/or increased exercise. Methods of using such profiles for the identification of pharmaceutical substances, nutraceutical substances, dietary substances, or treatment regimens that modulate or contribute to desired phenotypes in animals are also disclosed.
Patent MX-2011004614-A (MX)
Title: Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy.
Inventor: REILLY PAUL A
IPC: A61K31/4439
Filed: 2009-11-10
Abstract: A method for preventing stroke in a patient suffering from atrial fibrillation, wherein the patient has at least one risk factor for major bleeding events, the method comprising administering to the patient 110 mg b.i.d. of dabigatran etexilate, optionally in the form of a pharmaceutically acceptable salt thereof.
Patent MX-2011005391-A (MX)
Title: Method and apparatus for use of mixing elements in wastewater/ recycle water uv disinfection system.
Inventor: BIRCHER KEITH
IPC: B01J19/08
Filed: 2009-11-25
Abstract: An apparatus and method for mixing at least one fluid flowing through a fluid system using ultraviolet light to control organisms. Ultraviolet lamps are positioned in the fluid flow and arrays of triangularly shaped mixing elements are arranged at spaced intervals along the length of each lamp, wherein the plurality of arrays of triangularly shaped mixing elements create four vortices surrounding each elongated member forming a square array of vortices. An apparatus and method for mixing at least one fluid flowing through a fluid system using ultraviolet light to control organisms. Ultraviolet lamps are positioned in the fluid flow and arrays of triangularly shaped mixing elements are arranged at spaced intervals along the length of each lamp, wherein the plurality of arrays of triangularly shaped mixing elements create four vortices surrounding each elongated member forming a square array of vortices. The invention provides fabric conditioning compositions, which include as the conditioning agent, one or more quaternary ester ammonium salt compounds, which include a mixture of quaternary mono-, di- and tri-ester ammonium salt components, wherein the amount of quaternary diester ammonium salts is greater than about 40% by weight, and the amount of quaternary triester ammonium salts is less than about 20% by weight based on the total amount of quaternary ester ammonium salts. The composition contains a high level of quaternary diester ammonium salt content, and low level of quaternary triester ammonium salt content.
Patent MX-2011005606-A (MX)
Title: Split-bodied insulated cavity for a file cabinet.
Inventor: PALLO R DAVID
IPC: A47B88/00
Filed: 2011-05-26
Abstract: A file cabinet is provided and comprises an outer housing defining an opening, at least one file drawer assembly slidably disposed within the opening, the at least one file drawer assembly including an open-ended storage box, and a split-bodied fire-resistant cavity including first and second cavity portions. The first cavity portion is mounted within the outer housing, and the second cavity portion is mounted to the file drawer assembly and is configured to surround a portion of the open-ended storage box. A mating interface is provided between the first and second cavity portions. The open-ended storage box is accessible when the at least one file drawer assembly is in an open position. The first and second cavity portions are configured to join together at the mating interface to entirely surround the open-ended storage box when the at least one file drawer assembly is in a closed position.
Patent MX-2011005937-A (MX)
Title: Organic compounds.
Inventor: WENNOGLE LAWRENCE P
IPC: C07D491/00
Filed: 2009-12-07
Abstract: Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-thioxo or 4-imino)-(1Hor 2H)- imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4- thioxo or 4-imino)-(1Hor 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Patent MX-2011006079-A (MX)
Title: Solid-layered bleach compositions.
Inventor: SMITH WILLIAM L
IPC: C11D7/18
Filed: 2009-11-19
Abstract: The present invention provides a solid-layered bleach composition having at least two parts The first part comprises a) calcium hhypochlorite, magnesium hypochlorite and mixtures thereof, b) a builder, c) a water-soluble polymer, d) an acid, and e) wherein the first part does not contain sodium hypochlorite, lithium hypochlorite, potassium hypochlorite and mixtures thereof The second part comprises a) a surfactant, b) a builder, c) an acid, and d) wherein the second part does not contain any oxidant.
Patent MX-2011007620-A (MX)
Title: Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamid e, and crystalline forms therof for the treatment of cancer.
Inventor: LAMB PETER
IPC: A61K31/47
Filed: 2010-01-15
Abstract: Disclosed are malate salts of N-(4-{ [6,7-bis(methyloxy)-quinolin-4-yl]oxy}phenyl)- N'-(4-fluorophenyl)cyclopropane-l,l-dicarboxamide, including a (L)-malate salt, a (D)- malate salt, a (DL) malate salt, and mixtures thereof; and crystalline and amorphous forms of the malate salts. Also disclosed are pharmaceutical compositions comprising at least one malate salts of N-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl )- cyclopropane-l,l-dicarboxamide; and methods of treating cancer comprising administering at least one malate salt of N-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4- ffuorophenyl)cyclopropane- 1, 1 -dicarboxamide.
Patent MX-2011007924-A (MX)
Title: Apparatus, method and computer program for upmixing a downmix audio signal.
Inventor: HILPERT JOHANNES
IPC: H04B1/66
Filed: 2010-01-12
Abstract: An apparatus for upmixing a downmix audio signal describing one or more downmix audio channels into an upmixed audio signal describing a plurality of upmixed audio channels comprises an upmixer configured to apply temporally variable upmixing parameters to upmix the downmix audio signal in order to obtain the upmixed audio signal. The apparatus also comprises a parameter interpolator, wherein the parameter interpolator is configured to obtain one or more temporally interpolated upmix parameters to be used by the upmixer on the basis of a first complex-valued upmix parameter and a subsequent second complex-valued upmix parameter. The parameter interpolator is configured to separately interpolate between a magnitude value of the first complex-valued upmix parameter and a magnitude value of the second complex-valued upmix parameter, and between a phase value of the first complex-valued upmix parameter and a phase value of the second complex-valued upmix parameter, to obtain the one or more temporally interpolated upmix parameters. A respective method can be implemented, for example, as a computer program.
Patent MX-2011008913-A (MX)
Title: Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris.
Inventor: DAVIDSON ROBERT C
IPC: C12N9/12
Filed: 2010-02-24
Abstract: Lower eukaryotic cells such as Pichia pastoris that normally cannot use galactose as a carbon source but which have been genetically engineered according to the methods herein to use galactose as a sole source of carbon are described. The cells are genetically engineered to express several of the enzymes comprising the Leloir pathway. In particular, the cells are genetically engineered to express a galactokinase, a UDP-galactose-C4-epimerase, and a galactose-1-phosphate uridyltransferase, and optionally a galactose permease. In addition, a method is provided for improving the yield of glycoproteins that have galactose-terminated or -containing N-glycans in cells that have been genetically engineered to produce glycoproteins with N-glycans having galactose residues but which normally lack the enzymes comprising the Leloir pathway comprising transforming the cells with one or more nucleic acid molecules encoding a galactokinase, a UDP-galactose-C4-epimerase, and a galactose-1-phosphate uridyltransferase. The methods and host cells described enable the presence or lack of the ability to assimilate galactose as a selection method for making recombinant cells. The methods and host cells are shown herein to be particularly useful for making immunoglobulins and the like that have galactose-terminated or containing N-glycans.
Patent MX-2011010080-A (MX)
Title: Genetic severity markers in multiple sclerosis.
Inventor: ABDERRAHIM HADI
IPC: C12Q1/68
Filed: 2010-03-25
Abstract: The present invention relates to the use of SNPs in predicting susceptibility and/or severity of Multiple Sclerosis in an individual. The SNPs are located in the introns of the glycosylation enzymes MGAT5 and XYLTl, 3' of HIFlAN, within introns of MEGF11, FGF14, PDE9A and CDH13 and within desert regions of 4q34 and 17p13.
Patent MX-2011011711-A (MX)
Title: Smart packaging for detecting microorganisms.
Inventor: PUERTA M C CRISTINA NERIN DE LA
IPC: C12Q1/04
Filed: 2010-04-21
Abstract: The present invention relates to novel smart packaging, designed using a novel material comprising a partially polar adsorbent solid base impregnated with a solution of vanillin, which allows the growth of microorganisms in different types of products to be detected visually without having to be in direct contact with the microorganism or with the medium containing same.
Patent MX-2011012115-A (MX)
Title: Method for creating high carbon content products from biomass oil.
Inventor: SEAMES WAYNE
IPC: C07C1/00
Filed: 2010-05-14
Abstract: In a method for producing high carbon content products from biomass, a biomass oil is added to a cracking reactor vessel. The biomass oil is heated to a temperature ranging from about 100 Â°C to about 800 Â°C at a pressure ranging from about vacuum conditions to about 20,700 kPa for a time sufficient to crack the biomass oil. Tar is separated from the cracked biomass oil. The tar is heated to a temperature ranging from about 200 Â°C to about 1500 Â°C at a pressure ranging from about vacuum conditions to about 20,700 kPa for a time sufficient to reduce the tar to a high carbon content product containing at least about 50% carbon by weight.
Patent MX-2011013617-A (MX)
Title: Acid gas scrubbing composition.
Inventor: BLAIR ALAN M
IPC: B01D53/14
Filed: 2010-06-29
Abstract: This invention provides novel compositions comprising substituted polyamines as acid gas scrubbing solutions and methods of using the compositions in an industrial system. The invention relates to the use of such polyamine compounds in industrial processes to remove acidic contaminants from natural and industrial fluid streams, such as natural gas, combustion gas, natural gas, synthesis gas, biogas, and other industrial fluid streams. The compositions and methods of the invention are useful for removal, absorption, or sequestration of acidic contaminants and sulfide contaminants including CO2, H2S, RSH, CS2, COS, and SO2.
Patent MX-2012000959-A (MX)
Title: Inhibitors of flaviviridae viruses.
Inventor: CHONG LEE S
IPC: C07D487/04
Filed: 2010-07-19
Abstract: Provided are compounds of Formula I: (I) and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
Patent MX-2012001308-A (MX)
Title: Oral care device.
Inventor: MCDONOUGH JUSTIN
IPC: A61C17/028
Filed: 2010-07-29
Abstract: An oral care device suitable for use in providing a beneficial effect to an oral cavity of a mammal, which device includes means for providing reciprocation of a liquid effective for providing the beneficial effect of the oral cavity when the liquid is contacted with a plurality of surfaces thereof under conditions effective to provide the beneficial effect.
Patent MX-2012003211-A (MX)
Title: Container for liquids with air release valve.
Inventor: TORRES CARLOS ALBERTO PRIETO
IPC: F16K1/30
Filed: 2012-03-13
Abstract: The present invention refers to a container for liquids, which is operated by an air release valve installed in the upper portion thereof, when the container has no water inside, this is filled with air and forms a body that is driven by water, which needs to be released. This valve is the means for releasing the air, when the container is filled with water the valve is closed. The lower portion of the container has an orifice where a supply and discharge pipe is connected.
Patent MX-2012004518-A (MX)
Title: Audio signal encoder, audio signal decoder, method for providing an encoded representation of an audio content, method for providing a decoded representation of an audio content and computer program for use in low delay applications.
Inventor: SCHNELL MARKUS
IPC: G10L19/04
Filed: 2010-10-19
Abstract: An audio signal encoder (100) comprises a transform-domain path (12) configured to obtain a set of spectral coefficients (124) and noise-shaping information (126) on the basis of a time-domain representation (122) of a portion of the audio content to be encoded in a transform-domain mode. The transform-domain path comprises a time-domain-to-frequency-domain converter (130) configured to window a time-domain representation of the audio content, or a pre-processed version thereof, to obtain a windowed representation of the audio content, and to apply a time-domain-to-frequency-domain conversion, to derive a set of spectral coefficients from the windowed time-domain representation of the audio content. The audio signal decoder comprises a CELP path (140) configured to obtain an code-excitation information (144) and a linear-prediction-domain parameter information (146) on the basis of a portion of the audio content to be encoded in a CELP mode. The time-domain-to-frequency-domain converter (136) is configured to apply a predetermined asymmetric analysis window (520) for a windowing of a current portion of the audio content to be encoded in the transform-domain mode and following a portion of the audio content encoded in the transform-domain mode both if the current portion of the audio content is followed by a subsequent portion of the audio content to be encoded in the transform-domain mode and if the current portion of the audio content is followed by a subsequent portion of the audio content to be encoded in the CELP mode. The audio signal encoder is configured to selectively provide an aliasing cancellation information (164) if the current portion of the audio content is followed by a subsequent portion of the audio content to be encoded in the CELP mode.
Patent MX-2012006197-A (MX)
Title: Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle).
Inventor: BRUECHER CHRISTOPH
IPC: C07K16/24
Filed: 2010-11-30
Abstract: Provided is a humanized or chimeric antibody or fragment thereof capable of binding to interleukin-10 (IL-10), wherein said antibody or fragment thereof is capable of being administered to a subject in the absence of an intolerable increase in the level of pro-inflammatory cytokines. Further provided are methods of treatment involving the use of the antibody or fragment thereof.
Patent MX-2012006749-A (MX)
Title: Absorbent article comprising a malodor control composition having an acid catalyst.
Inventor: HORENZIAK STEVEN ANTHONY
IPC: C11D3/00
Filed: 2010-12-16
Abstract: An absorbent article comprising a malodor control composition having at least one volatile aldehyde and an acid catalyst, and methods of use thereof, are provided. The malodor control composition is suitable for a variety of absorbent articles, including use in diapers, toddler training pants, adult incontinence garments, sanitary napkins, pantiliners, interlabial devices, hemorrhoid pads, and the like.